Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Taylor

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Heart Transplantation|May 1, 1989
Hyperlipidemia after clinical heart transplantationD O Taylor, J A Thompson, A Hastillo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1992
Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effectsG D Price, S L Olsen, D O Taylor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
Suggested guidelines for the use of tacrolimus in cardiac transplant recipientsD O Taylor, M L Barr, B M Meiser, et al.
Journal of the American College of Cardiology|November 1, 1993
Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertensionT R Porter, D O Taylor, A Cycan, et al.
Transplantation|May 15, 1994
Paternity by cardiac transplant recipientsL E Wagoner, D O Taylor, G D Price, et al.
Transplantation|June 14, 2000
Cardiac transplantation in survivors of lymphoma: a multi-institutional surveyD O Taylor, H H Farhoud, G Kfoury, et al.
Transplantation|July 27, 1996
The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3)H Ma, E H Hammond, D O Taylor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 8, 1999
Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitizationJ C Stringham, D A Bull, T C Fuller, et al.
Transplantation|December 1, 1993
Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicityL E Wagoner, S L Olsen, M R Bristow, et al.
Transplantation Proceedings|July 13, 2010
The effect of recipient hepatitis C virus infection on outcomes following heart transplantationA E Shafii, J W Su, N G Smedira, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Heart Transplantation|May 1, 1989
Hyperlipidemia after clinical heart transplantationD O Taylor, J A Thompson, A Hastillo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1992
Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effectsG D Price, S L Olsen, D O Taylor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
Suggested guidelines for the use of tacrolimus in cardiac transplant recipientsD O Taylor, M L Barr, B M Meiser, et al.
Journal of the American College of Cardiology|November 1, 1993
Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertensionT R Porter, D O Taylor, A Cycan, et al.
Transplantation|May 15, 1994
Paternity by cardiac transplant recipientsL E Wagoner, D O Taylor, G D Price, et al.
Transplantation|June 14, 2000
Cardiac transplantation in survivors of lymphoma: a multi-institutional surveyD O Taylor, H H Farhoud, G Kfoury, et al.
Transplantation|July 27, 1996
The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3)H Ma, E H Hammond, D O Taylor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 8, 1999
Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitizationJ C Stringham, D A Bull, T C Fuller, et al.
Transplantation|December 1, 1993
Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicityL E Wagoner, S L Olsen, M R Bristow, et al.
Transplantation Proceedings|July 13, 2010
The effect of recipient hepatitis C virus infection on outcomes following heart transplantationA E Shafii, J W Su, N G Smedira, et al.
Pageof 8